Skip to main content

Want a detailed portfolio tracker?

Mangoceuticals (MGRX) P/E (2023 - 2026)

Mangoceuticals (MGRX) P/E from Mar 31, 2023 to Jul 20, 2026. The TTM Mangoceuticals (MGRX) P/E is -0.22. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mangoceuticals (MGRX)

YearP/EChange
2026-0.22-21.44%
2025-0.28-37.41%
2024-0.44-34.40%
2023-0.67N/A

Comparison Mangoceuticals (MGRX) P/E with competitors

Mangoceuticals (MGRX) P/E is -0.22.

TickerNameP/EUpside
ZCMDZhongchao Inc - Class A0.19-185.14%
CCLDCareCloud Inc10.17-4777.00%
SPOKSpok Holdings Inc17.15-7982.89%
OPRXOptimizeRx Corp18.19-8460.02%
DOCSDoximity Inc - Class A21.16-9827.02%
WAYWaystar Holding Corp32.86-15208.25%
VEEVVeeva Systems Inc - Class A34.21-15826.98%
HQYHealthequity Inc35.10-16235.47%
LFMDLifeMD Inc36.67-16956.90%
BTSGBrightSpring Health Services Inc41.63-19239.68%
TBRGTruBridge Inc41.65-19248.19%
HSTMHealthstream Inc41.98-19400.54%
GDRXGoodRx Holdings Inc - Class A42.61-19687.07%
SLPSimulations Plus Inc45.51-21021.11%
NRCNational Research Corp54.19-25012.73%
OMCLOmnicell Inc104.52-48149.13%
CCLDOCareCloud Inc119.05-54827.86%
BTSGUBrightSpring Health Services Inc136.30-62759.66%
PRVAPrivia Health Group Inc159.52-73431.79%
PHRPhreesia Inc167.24-76983.88%
TALKTalkspace Inc703.54-323524.24%